FORM N-PX
ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED MANAGEMENT INVESTMENT COMPANY
INVESTMENT COMPANY ACT FILE NUMBER: 811-03114
EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER: Fidelity Select Portfolios
Fund Name: Select Biotechnology Portfolio
82 DEVONSHIRE STREET, BOSTON, MA 02109
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE)
ERIC D. ROITER, SECRETARY, 82 DEVONSHIRE STREET, BOSTON, MA 02109
(NAME AND ADDRESS OF AGENT FOR SERVICE)
REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE: 617-563-7000
DATE OF FISCAL YEAR END: FEBRUARY 29
DATE OF REPORTING PERIOD: 06/30/2004
SIGNATURES
PURSUANT TO THE REQUIREMENTS OF THE INVESTMENT COMPANY ACT OF 1940, THE REGISTRANT HAS DULY CAUSED THIS REPORT TO BE SIGNED ON ITS BEHALF BY THE UNDERSIGNED, THERE UNTO DULY AUTHORIZED.
Fidelity Select Portfolios
BY: /s/ CHRISTINE REYNOLDS
-----------------------------------------------------
CHRISTINE REYNOLDS, TREASURER, FIDELITY MANAGEMENT & RESEARCH COMPANY
DATE: 08/25/2004 09:54:31 AM
EXHIBIT A
VOTE SUMMARY REPORT
Select Biotechnology Portfolio
07/01/2003 - 06/30/2004
Note: The Security ID will be the CUSIP (Committee on Uniform Securities Identification Procedures) when available. When CUSIP is not available, an alternate identifier, e.g., CINS, will be provided.
ISSUER NAME: ABGENIX, INC. MEETING DATE: 06/07/2004 | ||||
TICKER: ABGX SECURITY ID: 00339B107 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT R. SCOTT GREER AS A DIRECTOR | Management | For | For |
1.2 | ELECT M.K. BEHRENS, PH.D. AS A DIRECTOR | Management | For | For |
1.3 | ELECT R.S. KUCHERLAPATI, PHD AS A DIRECTOR | Management | For | For |
1.4 | ELECT KENNETH B. LEE, JR. AS A DIRECTOR | Management | For | For |
1.5 | ELECT MARK B. LOGAN AS A DIRECTOR | Management | For | For |
1.6 | ELECT THOMAS G. WIGGANS AS A DIRECTOR | Management | For | For |
1.7 | ELECT RAYMOND M. WITHY, PH.D. AS A DIRECTOR | Management | For | For |
ISSUER NAME: ACTELION LTD., ALLSCHWIL MEETING DATE: 04/30/2004 | ||||
TICKER: -- SECURITY ID: H0032X135 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | PLEASE NOTE THIS IS PART II OF MEETING NOTICE SENT UNDER MEETING #125009, INCLUDING THE AGENDA. TO VOTE IN THE UPCOMING MEETING, YOUR NAME MUST BE NOTIFIED TO THE COMPANY REGISTRAR AS BENEFICIAL OWNER BEFORE THE RE-REGISTRATION DEADLINE. THEREFORE, ADP CUTOFF DATE FOR THIS MEETING IS CALCULATED BASED ON THE RE-REGISTRATION DEADLINE SET BY THE MARKET. HOWEVER, SHAREHOLDERS THAT ARE ALREADY REGISTERED AT THE COMPANY BOOKS ARE ENTITLED TO SUBMIT THEIR VOTING INSTRUCTIONS UP UNTIL 04/19/2004 (ADP ... | N/A | N/A | N/A |
2 | THE PRACTICE OF SHARE BLOCKING VARIES WIDELY IN THIS MARKET. PLEASE CONTACT YOUR ADP CLIENT SERVICE REPRESENTATIVE TO OBTAIN BLOCKING INFORMATION FOR YOUR ACCOUNTS. | N/A | N/A | N/A |
3 | RECEIVE THE BUSINESS REPORT OF THE BOARD OF DIRECTORS WITH ANNUAL REPORT, THEANNUAL ACCOUNTS AND THE ACCOUNTS OF THE GROUP 2003 | Management | Unknown | Take No Action |
4 | RECEIVE THE REPORTS OF THE AUDITORS AND THE GROUP AUDITOR | Management | Unknown | Take No Action |
5 | APPROVE THE BUSINESS REPORT WITH ANNUAL ACCOUNTS AND THE ACCOUNTS OF THE GROUP 2003 | Management | Unknown | Take No Action |
6 | APPROVE THE APPROPRIATION OF THE BUSINESS RESULT | Management | Unknown | Take No Action |
7 | GRANT DISCHARGE TO THE BOARD OF DIRECTORS AND MANAGEMENT | Management | Unknown | Take No Action |
8 | ELECT THE BOARD OF DIRECTORS | Management | Unknown | Take No Action |
9 | ELECT THE AUDITORS AND THE GROUP AUDITOR | Management | Unknown | Take No Action |
10 | APPROVE THE MODIFICATION OF THE SHARE CAPITAL STRUCTURE AND THE MODIFICATION OF THE BY-LAWS | Management | Unknown | Take No Action |
11 | MISCELLANEOUS | Management | Unknown | Take No Action |
ISSUER NAME: AFFYMETRIX, INC. MEETING DATE: 06/10/2004 | ||||
TICKER: AFFX SECURITY ID: 00826T108 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT STEPHEN P.A. FODOR, PHD AS A DIRECTOR | Management | For | For |
1.2 | ELECT PAUL BERG, PH.D. AS A DIRECTOR | Management | For | For |
1.3 | ELECT JOHN D. DIEKMAN, PH.D. AS A DIRECTOR | Management | For | For |
1.4 | ELECT VERNON R. LOUCKS, JR. AS A DIRECTOR | Management | For | For |
1.5 | ELECT SUSAN E. SIEGEL AS A DIRECTOR | Management | For | For |
1.6 | ELECT DAVID B. SINGER AS A DIRECTOR | Management | For | For |
1.7 | ELECT JOHN A. YOUNG AS A DIRECTOR | Management | For | For |
2 | TO APPROVE OUR AMENDED AND RESTATED 2000 EQUITY INCENTIVE PLAN. | Management | For | For |
3 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG AS INDEPENDENT AUDITORS OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2004. | Management | For | For |
ISSUER NAME: ALKERMES, INC. MEETING DATE: 09/09/2003 | ||||
TICKER: ALKS SECURITY ID: 01642T108 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT FLOYD E. BLOOM AS A DIRECTOR | Management | For | Withhold |
1.2 | ELECT ROBERT A. BREYER AS A DIRECTOR | Management | For | Withhold |
1.3 | ELECT GERRI HENWOOD AS A DIRECTOR | Management | For | Withhold |
1.4 | ELECT PAUL J. MITCHELL AS A DIRECTOR | Management | For | Withhold |
1.5 | ELECT RICHARD F. POPS AS A DIRECTOR | Management | For | Withhold |
1.6 | ELECT ALEXANDER RICH AS A DIRECTOR | Management | For | Withhold |
1.7 | ELECT PAUL SCHIMMEL AS A DIRECTOR | Management | For | Withhold |
1.8 | ELECT MICHAEL A. WALL AS A DIRECTOR | Management | For | Withhold |
2 | TO APPROVE AN AMENDMENT TO THE 1999 STOCK OPTION PLAN TO INCREASE TO 14,400,000 THE NUMBER OF SHARES ISSUABLE UPON EXERCISE OF OPTIONS GRANTED THEREUNDER, AN INCREASE OF 3,000,000 SHARES. | Management | For | For |
3 | TO APPROVE AN AMENDMENT TO THE STOCK OPTION PLAN FOR NON-EMPLOYEE DIRECTORS TO INCREASE TO 1,000,000 THE NUMBER OF SHARES ISSUABLE UPON EXERCISE OF OPTIONS GRANTED THEREUNDER, AN INCREASE OF 500,000 SHARES. | Management | For | For |
ISSUER NAME: AMGEN INC. MEETING DATE: 05/13/2004 | ||||
TICKER: AMGN SECURITY ID: 031162100 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT MR. FRANK J. BIONDI, JR AS A DIRECTOR | Management | For | For |
1.2 | ELECT MR. JERRY D. CHOATE AS A DIRECTOR | Management | For | For |
1.3 | ELECT MR. FRANK C. HERRINGER AS A DIRECTOR | Management | For | For |
1.4 | ELECT DR. GILBERT S. OMENN AS A DIRECTOR | Management | For | For |
2 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS INDEPENDENT AUDITORS OF THE COMPANY FOR THE YEAR ENDING DECEMBER 31, 2004. | Management | For | For |
3 | STOCKHOLDER PROPOSAL #1 (EEO-1 REPORT). | Shareholder | Against | Against |
4 | STOCKHOLDER PROPOSAL #2 (STOCK OPTION EXPENSING). | Shareholder | Against | Against |
ISSUER NAME: AMYLIN PHARMACEUTICALS, INC. MEETING DATE: 05/05/2004 | ||||
TICKER: AMLN SECURITY ID: 032346108 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT VAUGHN D. BRYSON AS A DIRECTOR | Management | For | For |
1.2 | ELECT JOSEPH C. COOK, JR. AS A DIRECTOR | Management | For | For |
1.3 | ELECT GINGER L. GRAHAM AS A DIRECTOR | Management | For | For |
1.4 | ELECT HOWARD E. GREENE, JR. AS A DIRECTOR | Management | For | For |
1.5 | ELECT TERRANCE H. GREGG AS A DIRECTOR | Management | For | For |
1.6 | ELECT JAY S. SKYLER AS A DIRECTOR | Management | For | For |
1.7 | ELECT JOSEPH P. SULLIVAN AS A DIRECTOR | Management | For | For |
1.8 | ELECT THOMAS R. TESTMAN AS A DIRECTOR | Management | For | For |
1.9 | ELECT JAMES N. WILSON AS A DIRECTOR | Management | For | For |
2 | TO APPROVE AN INCREASE IN THE AGGREGATE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE COMPANY S 2001 EMPLOYEE STOCK PURCHASE PLAN BY 750,000 SHARES. | Management | For | For |
3 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS INDEPENDENT AUDITORS OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2004. | Management | For | For |
ISSUER NAME: BARR LABORATORIES, INC. MEETING DATE: 10/23/2003 | ||||
TICKER: BRL SECURITY ID: 068306109 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT BRUCE L. DOWNEY AS A DIRECTOR | Management | For | For |
1.2 | ELECT PAUL M. BISARO AS A DIRECTOR | Management | For | For |
1.3 | ELECT CAROLE S. BEN-MAIMON AS A DIRECTOR | Management | For | For |
1.4 | ELECT GEORGE P. STEPHAN AS A DIRECTOR | Management | For | For |
1.5 | ELECT JACK M. KAY AS A DIRECTOR | Management | For | For |
1.6 | ELECT HAROLD N. CHEFITZ AS A DIRECTOR | Management | For | For |
1.7 | ELECT RICHARD R. FRANKOVIC AS A DIRECTOR | Management | For | For |
1.8 | ELECT PETER R. SEAVER AS A DIRECTOR | Management | For | For |
1.9 | ELECT JAMES S. GILMORE, III AS A DIRECTOR | Management | For | For |
2 | APPROVAL OF THE REINCORPORATION OF THE COMPANY IN THE STATE OF DELAWARE. | Management | For | For |
3 | APPROVAL OF AN INCREASE IN THE NUMBER OF AUTHORIZED SHARES OF THE COMPANY S COMMON STOCK FROM 100,000,000 TO 200,000,000. | Management | For | For |
ISSUER NAME: BIOGEN IDEC INC. MEETING DATE: 06/16/2004 | ||||
TICKER: BIIB SECURITY ID: 09062X103 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT ALAN BELZER AS A DIRECTOR | Management | For | For |
1.2 | ELECT MARY L. GOOD AS A DIRECTOR | Management | For | For |
1.3 | ELECT JAMES C. MULLEN AS A DIRECTOR | Management | For | For |
1.4 | ELECT BRUCE R. ROSS AS A DIRECTOR | Management | For | For |
2 | TO RATIFY THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY S INDEPENDENT ACCOUNTANTS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2004. | Management | For | For |
ISSUER NAME: BIOGEN, INC. MEETING DATE: 11/12/2003 | ||||
TICKER: BGEN SECURITY ID: 090597105 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | TO APPROVE THE AGREEMENT AND PLAN OF MERGER, DATED AS OF JUNE 20, 2003, BY AND AMONG IDEC PHARMACEUTICALS CORPORATION, BRIDGES MERGER CORPORATION AND BIOGEN. | Management | For | For |
2 | TO APPROVE ANY PROPOSAL TO ADJOURN THE MEETING TO A LATER DATE, IF NECESSARY, TO SOLICIT ADDITIONAL PROXIES IF THERE ARE NOT SUFFICIENT VOTES IN FAVOR OF APPROVAL OF THE AGREEMENT AND PLAN OF MERGER. | Management | For | For |
ISSUER NAME: BIOMARIN PHARMACEUTICAL INC. MEETING DATE: 05/05/2004 | ||||
TICKER: BMRN SECURITY ID: 09061G101 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT FREDRIC D. PRICE AS A DIRECTOR | Management | For | For |
1.2 | ELECT FRANZ L. CRISTIANI AS A DIRECTOR | Management | For | For |
1.3 | ELECT ELAINE J. HERON AS A DIRECTOR | Management | For | For |
1.4 | ELECT PIERRE LAPALME AS A DIRECTOR | Management | For | For |
1.5 | ELECT ERICH SAGER AS A DIRECTOR | Management | For | For |
1.6 | ELECT JOHN URQUHART AS A DIRECTOR | Management | For | For |
1.7 | ELECT GWYNN R. WILLIAMS AS A DIRECTOR | Management | For | For |
2 | PROPOSAL TO RATIFY THE SELECTION BY THE BOARD OF DIRECTORS OF KPMG LLP AS THE COMPANY S INDEPENDENT AUDITORS FOR THE YEAR ENDING DECEMBER 31, 2004. | Management | For | For |
ISSUER NAME: BOSTON SCIENTIFIC CORPORATION MEETING DATE: 10/06/2003 | ||||
TICKER: BSX SECURITY ID: 101137107 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | TO APPROVE AN AMENDMENT TO THE COMPANY S SECOND RESTATED CERTIFICATE OF INCORPORATION. | Management | For | For |
ISSUER NAME: CELGENE CORPORATION MEETING DATE: 06/15/2004 | ||||
TICKER: CELG SECURITY ID: 151020104 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT JOHN W. JACKSON AS A DIRECTOR | Management | For | For |
1.2 | ELECT SOL J. BARER, PH.D. AS A DIRECTOR | Management | For | For |
1.3 | ELECT ROBERT J. HUGIN AS A DIRECTOR | Management | For | For |
1.4 | ELECT JACK L. BOWMAN AS A DIRECTOR | Management | For | For |
1.5 | ELECT FRANK T. CARY AS A DIRECTOR | Management | For | For |
1.6 | ELECT MICHAEL D. CASEY AS A DIRECTOR | Management | For | For |
1.7 | ELECT A. HULL HAYES, JR, M.D. AS A DIRECTOR | Management | For | For |
1.8 | ELECT GILLA KAPLAN, PH.D. AS A DIRECTOR | Management | For | For |
1.9 | ELECT RICHARD C.E. MORGAN AS A DIRECTOR | Management | For | For |
1.10 | ELECT WALTER L. ROBB, PH.D. AS A DIRECTOR | Management | For | For |
2 | PROPOSAL TO APPROVE AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO INCREASE THE TOTAL NUMBER OF SHARES OF STOCK THAT WE ARE AUTHORIZED TO ISSUE TO 280,000,000 | Management | For | For |
3 | PROPOSAL TO RATIFY THE APPOINTMENT OF KPMG LLP AS THE INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2004 | Management | For | For |
ISSUER NAME: CELL GENESYS, INC. MEETING DATE: 06/10/2004 | ||||
TICKER: CEGE SECURITY ID: 150921104 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT STEPHEN A. SHERWIN, MD AS A DIRECTOR | Management | For | For |
1.2 | ELECT DAVID W. CARTER AS A DIRECTOR | Management | For | For |
1.3 | ELECT NANCY M. CROWELL AS A DIRECTOR | Management | For | For |
1.4 | ELECT JAMES M. GOWER AS A DIRECTOR | Management | For | For |
1.5 | ELECT JOHN T. POTTS, JR, MD AS A DIRECTOR | Management | For | For |
1.6 | ELECT THOMAS E. SHENK, PH.D. AS A DIRECTOR | Management | For | For |
1.7 | ELECT EUGENE L. STEP AS A DIRECTOR | Management | For | For |
1.8 | ELECT INDER M. VERMA, PH.D. AS A DIRECTOR | Management | For | For |
1.9 | ELECT DENNIS L. WINGER AS A DIRECTOR | Management | For | For |
2 | TO APPROVE THE AMENDMENT OF THE COMPANY S 2001 NONSTATUTORY STOCK OPTION PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK RESERVED FOR FUTURE ISSUANCE BY 500,000 SHARES AND TO PROHIBIT FUTURE OPTION REPRICINGS UNDER THE 2001 NONSTATUTORY STOCK OPTION PLAN WITHOUT THE APPROVAL OF THE COMPANY S STOCKHOLDERS. | Management | For | Against |
3 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS INDEPENDENT AUDITORS OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2004. | Management | For | For |
4 | TO TRANSACT SUCH OTHER BUSINESS AS MAY PROPERLY COME BEFORE THE ANNUAL MEETING OR ANY ADJOURNMENT THEREOF. | Management | For | Abstain |
ISSUER NAME: CELL THERAPEUTICS, INC. MEETING DATE: 10/23/2003 | ||||
TICKER: CTIC SECURITY ID: 150934107 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | APPROVAL OF THE MERGER BETWEEN CELL THERAPEUTICS, INC. AND NOVUSPHARMA S.P.A. AND THE TRANSACTIONS CONTEMPLATED THEREBY AS SET FORTH IN THE MERGER AGREEMENT DATED AS OF JUNE 16, 2003 BETWEEN CTI AND NOVUSPHARMA. | Management | For | For |
ISSUER NAME: CELLTECH GROUP PLC MEETING DATE: 05/27/2004 | ||||
TICKER: -- SECURITY ID: G1990W102 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | RECEIVE THE REPORT OF THE DIRECTORS AND THE AUDITED ACCOUNTS FOR THE PERIOD ENDED 31 DEC 20032 | Management | Unknown | For |
2 | APPROVE THE DIRECTORS REMUNERATION REPORT FOR THE YE 31 DEC 2003 | Management | Unknown | For |
3 | ELECT DR. GORAN ANDO AS A DIRECTOR | Management | Unknown | For |
4 | ELECT MR. PETER CADBURY AS A DIRECTOR | Management | Unknown | For |
5 | ELECT MRS. INGELISE SAUNDERS AS A DIRECTOR | Management | Unknown | For |
6 | RE-APPOINT KPMG AUDIT PLC AS THE AUDITOR AND TO AUTHORIZE THE DIRECTORS TO FIX THEIR REMUNERATION | Management | Unknown | For |
7 | APPROVE TO RENEW THE DIRECTORS POWER TO ALLOT RELEVANT SECURITIES | Management | Unknown | For |
8 | APPROVE TO RENEW THE DIRECTORS POWER TO ALLOT EQUITY SECURITIES | Management | Unknown | For |
9 | AUTHORIZE THE COMPANY TO PURCHASE ITS OWN SHARES | Management | Unknown | For |
ISSUER NAME: CEPHALON, INC. MEETING DATE: 05/13/2004 | ||||
TICKER: CEPH SECURITY ID: 156708109 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT FRANK BALDINO,JR. PH.D. AS A DIRECTOR | Management | For | For |
1.2 | ELECT WILLIAM P. EGAN AS A DIRECTOR | Management | For | For |
1.3 | ELECT ROBERT J. FEENEY, PH.D. AS A DIRECTOR | Management | For | For |
1.4 | ELECT MARTYN D. GREENACRE AS A DIRECTOR | Management | For | For |
1.5 | ELECT CHARLES A. SANDERS, M.D AS A DIRECTOR | Management | For | For |
1.6 | ELECT GAIL R. WILENSKY, PH.D. AS A DIRECTOR | Management | For | For |
1.7 | ELECT DENNIS L. WINGER AS A DIRECTOR | Management | For | For |
1.8 | ELECT HORST WITZEL, DR.-ING. AS A DIRECTOR | Management | For | For |
2 | APPROVAL OF AN INCREASE IN THE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE COMPANY S 2004 EQUITY COMPENSATION PLAN (PREVIOUSLY KNOWN AS THE COMPANY S 1995 EQUITY COMPENSATION PLAN), THE EXTENSION OF THE TERM OF THE COMPANY S 2004 EQUITY COMPENSATION PLAN AND THE 2004 EQUITY COMPENSATION PLAN, AS AMENDED. | Management | For | For |
ISSUER NAME: CHIRON CORPORATION MEETING DATE: 05/27/2004 | ||||
TICKER: CHIR SECURITY ID: 170040109 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT VAUGHN D. BRYSON AS A DIRECTOR | Management | For | For |
1.2 | ELECT PIERRE E. DOUAZE AS A DIRECTOR | Management | For | For |
1.3 | ELECT EDWARD E. PENHOET AS A DIRECTOR | Management | For | For |
2 | TO APPROVE THE AMENDED AND RESTATED CHIRON 1991 STOCK OPTION PLAN, RENAMED THE CHIRON 2004 STOCK COMPENSATION PLAN. | Management | For | Against |
3 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS CHIRON S INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2004. | Management | For | For |
ISSUER NAME: DENDREON CORPORATION MEETING DATE: 06/16/2004 | ||||
TICKER: DNDN SECURITY ID: 24823Q107 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT GERARDO CANET AS A DIRECTOR | Management | For | For |
1.2 | ELECT BOGDAN DZIURZYNSKI AS A DIRECTOR | Management | For | For |
1.3 | ELECT DOUGLAS WATSON AS A DIRECTOR | Management | For | For |
ISSUER NAME: ELAN CORPORATION, PLC MEETING DATE: 06/17/2004 | ||||
TICKER: ELN SECURITY ID: 284131208 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | TO RECEIVE AND CONSIDER THE FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2003 TOGETHER WITH THE REPORTS OF THE DIRECTORS AND AUDITORS THEREON. | Management | For | For |
2 | TO RE-ELECT MR. BRENDAN BOUSHEL WHO RETIRES FROM THE BOARD BY ROTATION AS A DIRECTOR OF THE COMPANY. | Management | For | For |
3 | TO RE-ELECT MR. JOHN GROOM WHO RETIRES FROM THE BOARD BY ROTATION AS A DIRECTOR OF THE COMPANY. | Management | For | For |
4 | TO RE-ELECT MR. KYRAN MCLAUGHLIN WHO RETIRES FROM THE BOARD BY ROTATION AS A DIRECTOR OF THE COMPANY. | Management | For | For |
5 | TO RE-ELECT DR. DENNIS SELKOE WHO RETIRES FROM THE BOARD BY ROTATION AS A DIRECTOR OF THE COMPANY. | Management | For | For |
6 | TO RE-ELECT MR. DANIEL TULLY WHO RETIRES FROM THE BOARD BY ROTATION AS A DIRECTOR OF THE COMPANY. | Management | For | For |
7 | TO AUTHORISE THE DIRECTORS TO FIX THE REMUNERATION OF THE AUDITORS. | Management | For | For |
8 | THAT THE BOARD OF DIRECTORS BE AUTHORISED TO ISSUE SHARE OPTIONS TO NON-EXECUTIVE DIRECTORS IN ACCORDANCE WITH THE TERMS OF THE ELAN CORPORATION, PLC 1996 CONSULTANT OPTION PLAN. | Management | For | Abstain |
9 | THAT THE ELAN CORPORATION, PLC 2004 RESTRICTED STOCK PLAN ( THE RSU PLAN ) BE APPROVED AND ADOPTED. | Management | For | Abstain |
10 | THAT THE ELAN CORPORATION, PLC EMPLOYEE EQUITY PURCHASE PLAN ( THE ESPP ) BE APPROVED AND ADOPTED. | Management | For | For |
11 | THAT THE DIRECTORS BE AND ARE HEREBY GENERALLY AND UNCONDITIONALLY AUTHORISED TO ALLOT AND ISSUE ALL RELEVANT SECURITIES OF THE COMPANY. | Management | For | For |
12 | THAT THE AUTHORISED SHARE CAPITAL OF THE COMPANY BE INCREASED FROM 30,002,500 TO 33,502,500. | Management | For | For |
13 | THAT, SUBJECT TO THE PASSING OF RESOLUTION 12 IN THE NOTICE OF THIS MEETING, THE ARTICLES OF ASSOCIATION BE AMENDED. | Management | For | For |
14 | THAT, SUBJECT TO THE PASSING OF RESOLUTION 11 IN THE NOTICE OF THE MEETING, THE DIRECTORS BE AND ARE HEREBY EMPOWERED TO ALLOT SECURITIES FOR CASH. | Management | For | For |
15 | THAT THE COMPANY AND/OR ANY SUBSIDIARY OF THE COMPANY BE AND IS HEREBY GENERALLY AUTHORIZED TO MAKE MARKET PURCHASES OF SHARES OF ANY CLASS OF THE COMPANY. | Management | For | For |
16 | THAT THE RE-ISSUE PRICE RANGE AT WHICH ANY TREASURY SHARES FOR THE TIME BEING HELD BY THE COMPANY MAY BE RE-ISSUED OFF-MARKET SHALL BE THE MAXIMUM PRICE EQUAL TO 120 PER CENT OF THE RELEVANT PRICE; AND THE MINIMUM PRICE EQUAL TO 95 PER CENT OF THE RELEVANT PRICE. | Management | For | For |
ISSUER NAME: EPIX MEDICAL, INC. MEETING DATE: 05/26/2004 | ||||
TICKER: EPIX SECURITY ID: 26881Q101 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT STANLEY T CROOKE MD PHD AS A DIRECTOR | Management | For | For |
2 | PROPOSAL TO AMEND THE COMPANY S AMENDED AND RESTATED 1992 EQUITY INCENTIVE PLAN TO INCREASE THE AGGREGATE NUMBER OF SHARES OF THE COMPANY S COMMON STOCK AS TO WHICH AWARDS MAY BE GRANTED UNDER SUCH PLAN BY 500,000 SHARES. | Management | For | Against |
3 | PROPOSAL TO AMEND THE COMPANY S CERTIFICATE OF INCORPORATION TO CHANGE THE NAME OF THE COMPANY FROM EPIX MEDICAL, INC. TO EPIX PHARMACEUTICALS, INC. | Management | For | For |
4 | PROPOSAL TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT PUBLIC ACCOUNTANTS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2004. | Management | For | For |
ISSUER NAME: FIDELITY SECURITIES LENDING CASH CENTRAL FUND MEETING DATE: 04/14/2004 | ||||
TICKER: -- SECURITY ID: 31635A303 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | TO AMEND THE DECLARATION OF TRUST TO ALLOW THE BOARD OF TRUSTEES, IF PERMITTED BY APPLICABLE LAW, TO AUTHORIZE FUND MERGERS WITHOUT SHAREHOLDER APPROVAL. | Management | For | For |
2.1 | ELECT J. MICHAEL COOK AS A DIRECTOR | Management | For | For |
2.2 | ELECT RALPH F. COX AS A DIRECTOR | Management | For | For |
2.3 | ELECT LAURA B. CRONIN AS A DIRECTOR | Management | For | For |
2.4 | ELECT ROBERT M. GATES AS A DIRECTOR | Management | For | For |
2.5 | ELECT GEORGE H. HEILMEIER AS A DIRECTOR | Management | For | For |
2.6 | ELECT ABIGAIL P. JOHNSON AS A DIRECTOR | Management | For | For |
2.7 | ELECT EDWARD C. JOHNSON 3D AS A DIRECTOR | Management | For | For |
2.8 | ELECT DONALD J. KIRK AS A DIRECTOR | Management | For | For |
2.9 | ELECT MARIE L. KNOWLES AS A DIRECTOR | Management | For | For |
2.10 | ELECT NED C. LAUTENBACH AS A DIRECTOR | Management | For | For |
2.11 | ELECT MARVIN L. MANN AS A DIRECTOR | Management | For | For |
2.12 | ELECT WILLIAM O. MCCOY AS A DIRECTOR | Management | For | For |
2.13 | ELECT ROBERT L. REYNOLDS AS A DIRECTOR | Management | For | For |
2.14 | ELECT WILLIAM S. STAVROPOULOS AS A DIRECTOR | Management | For | For |
ISSUER NAME: GENENTECH, INC. MEETING DATE: 04/16/2004 | ||||
TICKER: DNA SECURITY ID: 368710406 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | TO APPROVE AN AMENDMENT TO THE BYLAWS WITH RESPECT TO THE NUMBER OF AUTHORIZED DIRECTORS. | Management | For | For |
2.1 | DIRECTORS | Management | For | For |
2.2 | DIRECTORS | Management | For | For |
2.3 | DIRECTORS | Management | For | For |
2.4 | DIRECTORS | Management | For | For |
2.5 | DIRECTORS | Management | For | For |
2.6 | DIRECTORS | Management | For | For |
2.7 | DIRECTORS | Management | For | For |
3 | ELECT WILLIAM M. BURNS AS DIRECTOR | Management | Unknown | For |
4 | ELECT ERICH HUNZIKER AS DIRECTOR | Management | Unknown | For |
5 | ELECT JONATHAN K.C. KNOWLES AS DIRECTOR | Management | Unknown | None |
6 | TO APPROVE AN AMENDMENT TO THE COMPANY S AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE AUTHORIZED SHARES OF COMMON STOCK | Management | For | For |
7 | TO APPROVE THE 2004 EQUITY INCENTIVE PLAN | Management | For | Against |
8 | TO RATIFY ERNST & YOUNG LLP AS OUR INDEPENDENT AUDITORS FOR 2004. | Management | For | For |
ISSUER NAME: GENZYME CORPORATION MEETING DATE: 05/27/2004 | ||||
TICKER: GENZ SECURITY ID: 372917104 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT DOUGLAS A. BERTHIAUME AS A DIRECTOR | Management | For | For |
1.2 | ELECT HENRY E. BLAIR AS A DIRECTOR | Management | For | For |
1.3 | ELECT GAIL K. BOUDREAUX AS A DIRECTOR | Management | For | For |
2 | A PROPOSAL TO AMEND THE 1999 EMPLOYEE STOCK PURCHASE PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK COVERED BY THE PLAN BY 1,500,000 SHARES. | Management | For | For |
3 | A PROPOSAL TO APPROVE THE 2004 EQUITY INCENTIVE PLAN. | Management | For | For |
4 | A PROPOSAL TO AMEND THE 1998 DIRECTORS STOCK OPTION PLAN TO (I) INCREASE THE NUMBER OF SHARES OF GENZYME GENERAL STOCK COVERED BY THE PLAN BY 200,000 SHARES AND (II) CHANGE THE FORMULA FOR MAKING ANNUAL OPTION GRANTS TO DIRECTORS. | Management | For | For |
5 | A PROPOSAL TO AMEND AND RESTATE OUR RESTATED ARTICLES OF ORGANIZATION. | Management | For | For |
6 | A PROPOSAL TO RATIFY OUR SELECTION OF INDEPENDENT AUDITORS. | Management | For | For |
7 | A SHAREHOLDER PROPOSAL TO REQUIRE THE GRANTING OF RESTRICTED STOCK IN LIEU OF STOCK OPTIONS. | Shareholder | Against | Against |
ISSUER NAME: GILEAD SCIENCES, INC. MEETING DATE: 05/25/2004 | ||||
TICKER: GILD SECURITY ID: 375558103 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT PAUL BERG AS A DIRECTOR | Management | For | Withhold |
1.2 | ELECT ETIENNE F. DAVIGNON AS A DIRECTOR | Management | For | Withhold |
1.3 | ELECT JAMES M. DENNY AS A DIRECTOR | Management | For | Withhold |
1.4 | ELECT JOHN C. MARTIN AS A DIRECTOR | Management | For | Withhold |
1.5 | ELECT GORDON E. MOORE AS A DIRECTOR | Management | For | Withhold |
1.6 | ELECT NICHOLAS G. MOORE AS A DIRECTOR | Management | For | Withhold |
1.7 | ELECT GEORGE P. SHULTZ AS A DIRECTOR | Management | For | Withhold |
1.8 | ELECT GAYLE E. WILSON AS A DIRECTOR | Management | For | Withhold |
2 | TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF ERNST & YOUNG LLP AS INDEPENDENT AUDITORS OF GILEAD FOR THE FISCAL YEAR ENDING DECEMBER 31, 2004. | Management | For | For |
3 | TO APPROVE THE ADOPTION OF GILEAD S 2004 EQUITY INCENTIVE PLAN. | Management | For | For |
4 | TO APPROVE AN AMENDMENT TO GILEAD S RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE AUTHORIZED NUMBER OF SHARES OF GILEAD COMMON STOCK FROM 500,000,000 TO 700,000,000 SHARES. | Management | For | For |
ISSUER NAME: GUILFORD PHARMACEUTICALS INC. MEETING DATE: 05/05/2004 | ||||
TICKER: GLFD SECURITY ID: 401829106 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT CRAIG R. SMITH, M.D. AS A DIRECTOR | Management | For | For |
1.2 | ELECT GEORGE L. BUNTING, JR. AS A DIRECTOR | Management | For | For |
1.3 | ELECT JOSEPH R. CHINNICI AS A DIRECTOR | Management | For | For |
1.4 | ELECT BARRY M. FOX AS A DIRECTOR | Management | For | For |
1.5 | ELECT ELIZABETH M. GREETHAM AS A DIRECTOR | Management | For | For |
1.6 | ELECT JOSEPH KLEIN, III AS A DIRECTOR | Management | For | For |
1.7 | ELECT RONALD M. NORDMANN AS A DIRECTOR | Management | For | For |
1.8 | ELECT SOLOMON H. SNYDER, M.D. AS A DIRECTOR | Management | For | For |
1.9 | ELECT DAVID C. U'PRICHARD PHD AS A DIRECTOR | Management | For | For |
2 | THE RATIFICATION OF THE SELECTION OF KPMG LLP AS THE COMPANY S INDEPENDENT AUDITOR FOR 2004. | Management | For | For |
3 | THE AMENDMENT OF THE COMPANY S AMENDED AND RESTATED CERTIFICATE OF INCORPORATION, AS AMENDED, TO INCREASE THE AUTHORIZED NUMBER OF SHARES OF OUR COMMON STOCK FROM 75,000,000 TO 125,000,000. | Management | For | For |
ISSUER NAME: HARVARD BIOSCIENCE, INC. MEETING DATE: 05/27/2004 | ||||
TICKER: HBIO SECURITY ID: 416906105 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT ROBERT DISHMAN AS A DIRECTOR | Management | For | For |
1.2 | ELECT NEAL J. HARTE AS A DIRECTOR | Management | For | For |
ISSUER NAME: HUMAN GENOME SCIENCES, INC. MEETING DATE: 05/20/2004 | ||||
TICKER: HGSI SECURITY ID: 444903108 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT RICHARD J DANZIG AS A DIRECTOR | Management | For | For |
1.2 | ELECT JURGEN DREWS MD AS A DIRECTOR | Management | For | For |
1.3 | ELECT KATHRYN E FALBERG AS A DIRECTOR | Management | For | For |
1.4 | ELECT ARGERIS N KARABELAS PHD AS A DIRECTOR | Management | For | For |
2 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2004. | Management | For | For |
3 | TO APPROVE AMENDMENT NO. 1 TO THE COMPANY S AMENDED AND RESTATED 2000 STOCK INCENTIVE PLAN (THE STOCK INCENTIVE PLAN ). | Management | For | For |
4 | TO APPROVE AMENDMENT NO. 2 TO THE STOCK INCENTIVE PLAN. | Management | For | For |
5 | TO APPROVE AN OPTION EXCHANGE PROGRAM FOR THE COMPANY S EMPLOYEES, OTHER THAN THE COMPANY S SEVEN EXECUTIVE OFFICERS. | Management | For | For |
ISSUER NAME: ICOS CORPORATION MEETING DATE: 05/14/2004 | ||||
TICKER: ICOS SECURITY ID: 449295104 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT PAUL N. CLARK AS A DIRECTOR | Management | For | For |
1.2 | ELECT VAUGHN D. BRYSON AS A DIRECTOR | Management | For | For |
1.3 | ELECT WILLIAM H. GATES III AS A DIRECTOR | Management | For | For |
1.4 | ELECT ROBERT W. PANGIA AS A DIRECTOR | Management | For | For |
2 | PROPOSAL TO RATIFY THE APPOINTMENT OF KPMG LLP AS ICOS INDEPENDENT AUDITORS FOR THE YEAR ENDING DECEMBER 31, 2004. | Management | For | For |
3 | STOCKHOLDER PROPOSAL REGARDING PERFORMANCE AND TIME-BASED RESTRICTED SHARES. | Shareholder | Against | Against |
ISSUER NAME: IDEC PHARMACEUTICALS CORPORATION MEETING DATE: 11/12/2003 | ||||
TICKER: IDPH SECURITY ID: 449370105 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | PROPOSAL TO APPROVE THE ISSUANCE OF SHARES OF IDEC PHARMACEUTICALS CORPORATION COMMON STOCK UNDER THE AGREEMENT AND PLAN OF MERGER, DATED AS OF JUNE 20, 2003, BY AND AMONG IDEC, BRIDGES MERGER CORPORATION AND BIOGEN, INC. | Management | For | For |
2 | PROPOSAL TO AMEND IDEC PHARMACEUTICAL CORPORATION S CERTIFICATE OF INCORPORATION TO INCREASE THE AUTHORIZED SHARES OF COMMON STOCK FROM 500,000,000 TO 1,000,000,000 AND TO CHANGE THE NAME OF THE CORPORATION TO BIOGEN IDEC INC., EFFECTIVE UPON COMPLETION OF THE MERGER. | Management | For | For |
3 | PROPOSAL TO APPROVE THE 2003 OMNIBUS EQUITY PLAN, EFFECTIVE UPON COMPLETION OF THE MERGER. | Management | For | For |
4 | PROPOSAL TO APPROVE THE PERFORMANCE BASED MANAGEMENT INCENTIVE PLAN, EFFECTIVE UPON COMPLETION OF THE MERGER. | Management | For | For |
5 | PROPOSAL TO ADJOURN THE SPECIAL MEETING, IF NECESSARY, TO SOLICIT ADDITIONAL PROXIES IF THERE ARE NOT SUFFICIENT VOTES IN FAVOR OF THE FOREGOING PROPOSALS. | Management | For | Abstain |
ISSUER NAME: IMCLONE SYSTEMS INCORPORATED MEETING DATE: 09/15/2003 | ||||
TICKER: IMCL SECURITY ID: 45245W109 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT ANDREW G. BODNAR AS A DIRECTOR | Management | For | For |
1.2 | ELECT VINCENT T. DEVITA, JR. AS A DIRECTOR | Management | For | For |
1.3 | ELECT JOHN A. FAZIO AS A DIRECTOR | Management | For | For |
1.4 | ELECT DAVID M. KIES AS A DIRECTOR | Management | For | For |
1.5 | ELECT WILLIAM R. MILLER AS A DIRECTOR | Management | For | For |
2 | APPROVAL OF AN AMENDMENT TO THE IMCLONE SYSTEMS INCORPORATED 2002 STOCK OPTION PLAN (THE 2002 OPTION PLAN ) TO INCREASE THE NUMBER OF SHARES AUTHORIZED TO BE ISSUED UNDER THE 2002 OPTION PLAN. | Management | For | Against |
3 | APPROVAL OF THE IMCLONE SYSTEMS INCORPORATED ANNUAL INCENTIVE PLAN. | Management | For | For |
4 | RATIFICATION OF THE APPOINTMENT OF KPMG LLP TO SERVE AS THE COMPANY S INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2003. | Management | For | For |
ISSUER NAME: IMCLONE SYSTEMS INCORPORATED MEETING DATE: 06/17/2004 | ||||
TICKER: IMCL SECURITY ID: 45245W109 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT ANDREW G. BODNAR AS A DIRECTOR | Management | For | For |
1.2 | ELECT WILLIAM W. CROUSE AS A DIRECTOR | Management | For | For |
1.3 | ELECT VINCENT T. DEVITA, JR. AS A DIRECTOR | Management | For | For |
1.4 | ELECT JOHN A. FAZIO AS A DIRECTOR | Management | For | For |
1.5 | ELECT JOSEPH L. FISCHER AS A DIRECTOR | Management | For | For |
1.6 | ELECT DAVID M. KIES AS A DIRECTOR | Management | For | For |
1.7 | ELECT DANIEL S. LYNCH AS A DIRECTOR | Management | For | For |
1.8 | ELECT WILLIAM R. MILLER AS A DIRECTOR | Management | For | For |
1.9 | ELECT DAVID SIDRANSKY AS A DIRECTOR | Management | For | For |
2 | RATIFICATION OF THE APPOINTMENT OF KPMG LLP TO SERVE AS THE COMPANY S INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2004. | Management | For | For |
ISSUER NAME: IMMUNOMEDICS, INC. MEETING DATE: 12/03/2003 | ||||
TICKER: IMMU SECURITY ID: 452907108 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT DAVID M. GOLDENBERG AS A DIRECTOR | Management | For | For |
1.2 | ELECT CYNTHIA L. SULLIVAN AS A DIRECTOR | Management | For | For |
1.3 | ELECT MORTON COLEMAN AS A DIRECTOR | Management | For | For |
1.4 | ELECT MARVIN E. JAFFE AS A DIRECTOR | Management | For | For |
1.5 | ELECT MARY E. PAETZOLD AS A DIRECTOR | Management | For | For |
1.6 | ELECT RICHARD R. PIVIROTTO AS A DIRECTOR | Management | For | For |
2 | PROPOSAL TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING JUNE 30, 2004. | Management | For | For |
ISSUER NAME: INVITROGEN CORPORATION MEETING DATE: 04/29/2004 | ||||
TICKER: IVGN SECURITY ID: 46185R100 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT RAYMOND V. DITTAMORE AS A DIRECTOR | Management | For | For |
1.2 | ELECT BRADLEY G. LORIMIER AS A DIRECTOR | Management | For | For |
1.3 | ELECT DAVID U'PRICHARD, PH.D. AS A DIRECTOR | Management | For | For |
2 | RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS INDEPENDENT AUDITORS OF THE COMPANY FOR FISCAL YEAR 2004 | Management | For | For |
3 | ADOPTION OF THE COMPANY S 2004 EQUITY INCENTIVE PLAN | Management | For | For |
4 | AMENDMENT OF THE COMPANY S 1998 EMPLOYEE STOCK PURCHASE PLAN | Management | For | For |
ISSUER NAME: KERYX BIOPHARMACEUTICALS, INC. MEETING DATE: 06/10/2004 | ||||
TICKER: KERX SECURITY ID: 492515101 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT MICHAEL S. WEISS AS A DIRECTOR | Management | For | For |
1.2 | ELECT I.C. HENDERSON, M.D. AS A DIRECTOR | Management | For | For |
1.3 | ELECT MALCOLM HOENLEIN AS A DIRECTOR | Management | For | For |
1.4 | ELECT PETER M. KASH AS A DIRECTOR | Management | For | For |
1.5 | ELECT L. JAY KESSEL, M.D. AS A DIRECTOR | Management | For | For |
1.6 | ELECT L.A. ROSENWALD, M.D. AS A DIRECTOR | Management | For | For |
1.7 | ELECT PETER SALOMON, M.D. AS A DIRECTOR | Management | For | For |
2 | SUBJECT TO THE ACHIEVEMENT OF CERTAIN MILESTONES, THE ISSUANCE OF UP TO 3,372,422 SHARES OF COMMON STOCK TO THE FORMER STOCKHOLDERS OF ACCESS ONCOLOGY, INC. (IN LIEU OF CASH HAVING AN EQUIVALENT VALUE THAT WILL OTHERWISE BE DELIVERABLE). | Management | For | For |
3 | APPROVAL OF OUR 2004 LONG-TERM INCENTIVE PLAN. | Management | For | Against |
4 | APPROVAL OF THE DELISTING OF OUR COMMON STOCK FROM THE ALTERNATIVE INVESTMENT MARKET OF THE LONDON STOCK EXCHANGE. | Management | For | For |
5 | APPROVAL OF THE AMENDMENT OF OUR CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF OUR COMMON STOCK. | Management | For | For |
ISSUER NAME: LIGAND PHARMACEUTICALS INCORPORATED MEETING DATE: 06/11/2004 | ||||
TICKER: LGND SECURITY ID: 53220K207 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT HENRY F. BLISSENBACH AS A DIRECTOR | Management | For | For |
1.2 | ELECT ALEXANDER D. CROSS AS A DIRECTOR | Management | For | For |
1.3 | ELECT JOHN GROOM AS A DIRECTOR | Management | For | For |
1.4 | ELECT IRVING S. JOHNSON AS A DIRECTOR | Management | For | For |
1.5 | ELECT JOHN W. KOZARICH AS A DIRECTOR | Management | For | For |
1.6 | ELECT CARL PECK AS A DIRECTOR | Management | For | For |
1.7 | ELECT DAVID E. ROBINSON AS A DIRECTOR | Management | For | For |
1.8 | ELECT MICHAEL A. ROCCA AS A DIRECTOR | Management | For | For |
2 | AMENDMENT OF 2002 STOCK OPTION/STOCK ISSUANCE PLAN. | Management | For | Against |
3 | AMENDMENT TO COMPANY S AMENDED AND RESTATED CERTIFICATE OF INCORPORATION. | Management | For | For |
4 | APPOINTMENT OF INDEPENDENT AUDITORS. | Management | For | For |
ISSUER NAME: MEDAREX, INC. MEETING DATE: 05/19/2004 | ||||
TICKER: MEDX SECURITY ID: 583916101 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT MR. IRWIN LERNER AS A DIRECTOR | Management | For | For |
1.2 | ELECT DR. JULIUS A. VIDA AS A DIRECTOR | Management | For | For |
2 | THE RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS INDEPENDENT AUDITORS FOR THE CURRENT FISCAL YEAR. | Management | For | For |
ISSUER NAME: MEDIMMUNE, INC. MEETING DATE: 05/20/2004 | ||||
TICKER: MEDI SECURITY ID: 584699102 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT WAYNE T. HOCKMEYER AS A DIRECTOR | Management | For | For |
1.2 | ELECT DAVID M. MOTT AS A DIRECTOR | Management | For | For |
1.3 | ELECT DAVID BALTIMORE AS A DIRECTOR | Management | For | For |
1.4 | ELECT M. JAMES BARRETT AS A DIRECTOR | Management | For | For |
1.5 | ELECT MELVIN D. BOOTH AS A DIRECTOR | Management | For | For |
1.6 | ELECT JAMES H. CAVANAUGH AS A DIRECTOR | Management | For | For |
1.7 | ELECT BARBARA H. FRANKLIN AS A DIRECTOR | Management | For | For |
1.8 | ELECT GORDON S. MACKLIN AS A DIRECTOR | Management | For | For |
1.9 | ELECT ELIZABETH H.S. WYATT AS A DIRECTOR | Management | For | For |
2 | TO APPROVE THE 2004 STOCK INCENTIVE PLAN | Management | For | Against |
3 | TO APPROVE AND RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS INDEPENDENT AUDITORS FOR 2004 | Management | For | For |
ISSUER NAME: MGI PHARMA, INC. MEETING DATE: 05/11/2004 | ||||
TICKER: MOGN SECURITY ID: 552880106 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT ANDREW J. FERRARA AS A DIRECTOR | Management | For | For |
1.2 | ELECT GILLA KAPLAN, PH.D. AS A DIRECTOR | Management | For | For |
1.3 | ELECT EDWARD W. MEHRER AS A DIRECTOR | Management | For | For |
1.4 | ELECT HUGH E. MILLER AS A DIRECTOR | Management | For | For |
1.5 | ELECT LEON O. MOULDER, JR. AS A DIRECTOR | Management | For | For |
1.6 | ELECT LEE J. SCHROEDER AS A DIRECTOR | Management | For | For |
1.7 | ELECT DAVID B. SHARROCK AS A DIRECTOR | Management | For | For |
1.8 | ELECT WANETA C. TUTTLE, PH.D. AS A DIRECTOR | Management | For | For |
1.9 | ELECT ARTHUR L. WEAVER, M.D. AS A DIRECTOR | Management | For | For |
2 | TO AMEND THE 1997 STOCK INCENTIVE PLAN TO EXTEND THE TERM OF THIS PLAN THROUGH MAY 31, 2008 AND TO INCREASE THE NUMBER OF SHARES AVAILABLE FOR AWARDS GRANTED UNDER THE PLAN BY 2,055,000 SHARES. | Management | For | For |
3 | TO AMEND THE AMENDED AND RESTATED EMPLOYEE STOCK PURCHASE PLAN TO INCREASE THE NUMBER OF SHARES WHICH MAY BE PURCHASED UNDER THE PLAN BY 500,000 SHARES. | Management | For | For |
4 | TO RATIFY THE APPOINTMENT OF KPMG LLP AS INDEPENDENT AUDITORS FOR THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2004. | Management | For | For |
ISSUER NAME: MILLENNIUM PHARMACEUTICALS, INC. MEETING DATE: 05/07/2004 | ||||
TICKER: MLNM SECURITY ID: 599902103 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT CHARLES J. HOMCY, M.D. AS A DIRECTOR | Management | For | For |
1.2 | ELECT RAJU S KUCHERLAPATI PHD AS A DIRECTOR | Management | For | For |
1.3 | ELECT ERIC S. LANDER, PH.D. AS A DIRECTOR | Management | For | For |
2 | RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2004. | Management | For | For |
ISSUER NAME: MYOGEN, INC. MEETING DATE: 05/12/2004 | ||||
TICKER: MYOG SECURITY ID: 62856E104 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT J. WILLIAM FREYTAG AS A DIRECTOR | Management | For | For |
1.2 | ELECT MICHAEL R. BRISTOW AS A DIRECTOR | Management | For | For |
1.3 | ELECT KIRK K. CALHOUN AS A DIRECTOR | Management | For | For |
1.4 | ELECT JERRY T. JACKSON AS A DIRECTOR | Management | For | For |
1.5 | ELECT DANIEL J. MITCHELL AS A DIRECTOR | Management | For | For |
1.6 | ELECT ARNOLD L. ORONSKY AS A DIRECTOR | Management | For | For |
1.7 | ELECT ANDREW N. SCHIFF AS A DIRECTOR | Management | For | For |
1.8 | ELECT SIGRID VAN BLADEL AS A DIRECTOR | Management | For | For |
2 | TO RATIFY SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF PRICEWATERHOUSECOOPERS LLP AS INDEPENDENT AUDITORS OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2004. | Management | For | For |
ISSUER NAME: NEUROCRINE BIOSCIENCES, INC. MEETING DATE: 05/26/2004 | ||||
TICKER: NBIX SECURITY ID: 64125C109 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT RICHARD F. POPS AS A DIRECTOR | Management | For | For |
1.2 | ELECT STEPHEN A. SHERWIN, MD AS A DIRECTOR | Management | For | For |
2 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT PUBLIC ACCOUNTANTS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2004. | Management | For | For |
3 | TO APPROVE AN AMENDMENT TO THE COMPANY S 2003 INCENTIVE STOCK PLAN INCREASING THE NUMBER OF SHARES OF COMMON STOCK RESERVED FOR ISSUANCE FROM 1,100,000 TO 2,300,000 SHARES. | Management | For | Against |
ISSUER NAME: NPS PHARMACEUTICALS, INC. MEETING DATE: 05/20/2004 | ||||
TICKER: NPSP SECURITY ID: 62936P103 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT SANTO J. COSTA AS A DIRECTOR | Management | For | For |
1.2 | ELECT JOHN R. EVANS AS A DIRECTOR | Management | For | For |
1.3 | ELECT JAMES G. GRONINGER AS A DIRECTOR | Management | For | For |
1.4 | ELECT HUNTER JACKSON AS A DIRECTOR | Management | For | For |
1.5 | ELECT JOSEPH KLEIN III AS A DIRECTOR | Management | For | For |
1.6 | ELECT DONALD E. KUHLA AS A DIRECTOR | Management | For | For |
1.7 | ELECT THOMAS N. PARKS AS A DIRECTOR | Management | For | For |
1.8 | ELECT CALVIN R. STILLER AS A DIRECTOR | Management | For | For |
1.9 | ELECT PETER G. TOMBROS AS A DIRECTOR | Management | For | For |
2 | TO RATIFY THE SELECTION OF KPMG LLP AS INDEPENDENT AUDITORS OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2004. | Management | For | For |
ISSUER NAME: NUVELO, INC. MEETING DATE: 05/06/2004 | ||||
TICKER: NUVO SECURITY ID: 67072M301 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT MARK L. PERRY AS A DIRECTOR | Management | For | For |
1.2 | ELECT BARRY L. ZUBROW AS A DIRECTOR | Management | For | For |
2 | APPROVAL OF THE 2004 EQUITY INCENTIVE PLAN | Management | For | For |
3 | RATIFICATION OF THE SELECTION OF KPMG LLP AS OUR INDEPENDENT AUDITORS FOR THE FISCAL YEAR 2004 | Management | For | For |
ISSUER NAME: PHARMION CORPORATION MEETING DATE: 06/02/2004 | ||||
TICKER: PHRM SECURITY ID: 71715B409 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT BRIAN ATWOOD AS A DIRECTOR | Management | For | For |
1.2 | ELECT M. JAMES BARRETT AS A DIRECTOR | Management | For | For |
1.3 | ELECT JAY MOORIN AS A DIRECTOR | Management | For | For |
2 | TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF ERNST & YOUNG LLP AS INDEPENDENT AUDITORS OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2004. | Management | For | For |
ISSUER NAME: PROTEIN DESIGN LABS, INC. MEETING DATE: 06/30/2004 | ||||
TICKER: PDLI SECURITY ID: 74369L103 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT LAURENCE JAY KORN, PHD AS A DIRECTOR | Management | For | For |
1.2 | ELECT MAX LINK, PHD AS A DIRECTOR | Management | For | For |
2 | TO APPROVE THE 2004 EQUITY INCENTIVE PLAN. | Management | For | Against |
3 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2004. | Management | For | For |
ISSUER NAME: REGENERON PHARMACEUTICALS, INC. MEETING DATE: 06/11/2004 | ||||
TICKER: REGN SECURITY ID: 75886F107 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT L S SCHLEIFER MD PHD AS A DIRECTOR | Management | For | For |
1.2 | ELECT ERIC M SHOOTER PHD AS A DIRECTOR | Management | For | For |
1.3 | ELECT G D YANCOPOULOS MD PHD AS A DIRECTOR | Management | For | For |
2 | TO APPROVE THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS INDEPENDENT ACCOUNTANTS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2004. | Management | For | For |
3 | TO AMEND THE 2000 LONG-TERM INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES RESERVED FOR ISSUANCE THEREUNDER BY 7,500,000 SHARES. | Management | For | Against |
ISSUER NAME: SEATTLE GENETICS, INC. MEETING DATE: 05/17/2004 | ||||
TICKER: SGEN SECURITY ID: 812578102 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT MARC E. LIPPMAN, M.D. AS A DIRECTOR | Management | For | For |
1.2 | ELECT DOUGLAS G. SOUTHERN AS A DIRECTOR | Management | For | For |
2 | PROPOSAL TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE INDEPENDENT ACCOUNTANTS OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2004. | Management | For | For |
ISSUER NAME: SEPRACOR INC. MEETING DATE: 05/19/2004 | ||||
TICKER: SEPR SECURITY ID: 817315104 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT DIGBY W. BARRIOS AS A DIRECTOR | Management | For | For |
1.2 | ELECT ALAN A. STEIGROD AS A DIRECTOR | Management | For | For |
2 | TO APPROVE AN AMENDMENT TO OUR 2000 STOCK INCENTIVE PLAN INCREASING FROM 5,500,000 TO 8,000,000 THE NUMBER OF SHARES OF OUR COMMON STOCK RESERVED FOR ISSUANCE UNDER THE 2000 PLAN. | Management | For | For |
3 | TO RATIFY THE SELECTION BY OUR BOARD OF DIRECTORS OF PRICEWATERHOUSECOOPERS LLP AS OUR INDEPENDENT AUDITORS FOR THE CURRENT FISCAL YEAR. | Management | For | For |
ISSUER NAME: SEROLOGICALS CORPORATION MEETING DATE: 05/12/2004 | ||||
TICKER: SERO SECURITY ID: 817523103 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT R E CHRISTOFFERSEN, PHD AS A DIRECTOR | Management | For | For |
1.2 | ELECT DESMOND H. O'CONNELL JR AS A DIRECTOR | Management | For | For |
1.3 | ELECT GEORGE M. SHAW, MD, PHD AS A DIRECTOR | Management | For | For |
ISSUER NAME: SHIRE PHARMACEUTICALS GROUP PLC MEETING DATE: 06/16/2004 | ||||
TICKER: SHPGY SECURITY ID: 82481R106 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | TO RECEIVE AND CONSIDER THE DIRECTORS REPORT AND ACCOUNTS FOR THE YEAR ENDED DECEMBER 31, 2003. | Management | For | For |
2 | TO RE-ELECT DR JAMES HENRY CAVANAUGH AS A DIRECTOR. | Management | For | For |
3 | TO RE-ELECT DR BARRY JOHN PRICE AS A DIRECTOR. | Management | For | For |
4 | TO ELECT MR ROBIN WILLIAM TURNBULL BUCHANAN AS A DIRECTOR. | Management | For | For |
5 | TO ELECT MR DAVID JOHN KAPPLER AS A DIRECTOR. | Management | For | For |
6 | TO RE-APPOINT DELOITTE & TOUCHE LLP AS AUDITORS AND AUTHORIZE THE AUDIT COMMITTEE TO FIX THEIR REMUNERATION. | Management | For | For |
7 | TO APPROVE THE DIRECTORS REMUNERATION REPORT. | Management | For | For |
8 | TO AUTHORIZE THE ALLOTMENT OF SHARES. | Management | For | For |
9 | TO AUTHORIZE THE DISAPPLICATION OF PRE-EMPTION RIGHTS. | Management | For | For |
10 | TO AUTHORIZE MARKET PURCHASES. | Management | For | For |
11 | TO AUTHORIZE DONATIONS TO EU POLITICAL ORGANIZATIONS AND EU POLITICAL EXPENDITURE. | Management | For | For |
ISSUER NAME: SKYEPHARMA PLC MEETING DATE: 06/23/2004 | ||||
TICKER: -- SECURITY ID: G1145K144 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | RECEIVE AND ADOPT THE ANNUAL REPORT AND ACCOUNTS FOR THE YE 31 DEC 2003 | Management | Unknown | For |
2 | APPROVE THE DIRECTORS REMUNERATION REPORT CONTAINED IN THE ANNUAL REPORT AND THE ACCOUNTS FOR THE FYE 31 DEC 2003 | Management | Unknown | For |
3 | APPROVE THE REMUNERATION COMMITTEE S POLICY FOR EXECUTIVE REMUNERATION FOR 2004 DESCRIBED FULLY IN THIS DOCUMENT | Management | Unknown | For |
4 | APPROVE THE ADDITION AND NATURE OF THE PERFORMANCE CONDITIONS TO BE ATTACHED TO FUTURE AWARDS OF MATCHING SHARES PROVIDED UNDER THE SKYEPHARMA PLC DEFERRED SHARE BONUS PLAN AS DESCRIBED FULLY IN THIS DOCUMENT | Management | Unknown | For |
5 | APPROVE THE OPERATION OF THE LONG-TERM INCENTIVE ELEMENT OF THE SKYEPHARMA PLC DEFERRED SHARE BONUS PLAN AS DESCRIBED FULLY IN THIS DOCUMENT | Management | Unknown | For |
6 | RE-APPOINT PRICEWATERHOUSECOOPERS LLP AS THE AUDITORS OF THE COMPANY UNTIL THE CONCLUSION OF THE NEXT GENERAL MEETING AT WHICH THE ACCOUNTS ARE LAID BEFORE THE COMPANY AND AUTHORIZE THE DIRECTORS TO FIX THEIR REMUNERATION | Management | Unknown | For |
7 | RE-ELECT MR. IAN GOWRIE-SMITH AS A DIRECTOR, WHO RETIRES BY ROTATION IN ACCORDANCE WITH THE ARTICLES OF ASSOCIATION OF THE COMPANY | Management | Unknown | For |
8 | RE-ELECT MR. DONALD NICHOLSON AS A DIRECTOR, WHO RETIRES BY ROTATION IN ACCORDANCE WITH THE ARTICLES OF ASSOCIATION OF THE COMPANY | Management | Unknown | For |
9 | RE-ELECT MR. DAVID EBSWORTH AS A DIRECTOR, WHO RETIRES BY ROTATION IN ACCORDANCE WITH THE ARTICLES OF ASSOCIATION OF THE COMPANY | Management | Unknown | For |
10 | RE-ELECT SIR MICHAEL BEAVIS AS A DIRECTOR, WHO RETIRES IN ACCORDANCE WITH SECTION 293 OF THE COMPANIES ACT 1985 THE ACT | Management | Unknown | For |
11 | RE-ELECT DR. KEITH MANSFORD AS A DIRECTOR, WHO RETIRES IN ACCORDANCE WITH SECTION 293 OF THE ACT | Management | Unknown | For |
12 | AUTHORIZE THE DIRECTORS, PURSUANT TO SECTION 80 OF THE ACT, TO ALLOT RELEVANT SECURITIES SECTION 80 UP TO AN AGGREGATE NOMINAL AMOUNT OF GBP 20,622,331, WHICH REPRESENTS APPROXIMATELY 1/3RD OF THE COMPANY S ISSUED ORDINARY SHARE CAPITAL AS AT 31 DEC 2003; AUTHORITY EXPIRES AT THE CONCLUSION OF THE NEXT AGM OF THE COMPANY AFTER THE DATE OF PASSING OF THIS RESOLUTION ; AND THE DIRECTORS MAY ALLOT RELEVANT SECURITIES AFTER THE EXPIRY OF THIS AUTHORITY IN PURSUANCE OF SUCH AN OFFER OR AGREEMENT M... | Management | Unknown | For |
13 | AUTHORIZE THE DIRECTORS TO ALLOT EQUITY SECURITIES SECTION 89 OF THE ACT FOR CASH PURSUANT TO THE AUTHORITY CONFERRED ON THEM UNDER SECTION 80 OF THE ACT AND TO SELL OR MAKE OFFERS OR AGREEMENTS TO SELL EQUITY SECURITIES WHICH IMMEDIATELY BEFORE THE SALE ARE HELD BY THE COMPANY AS TREASURY SHARES SECTION 162A OF THE ACT IN EACH CASE, DISAPPLYING THE STATUTORY PRE-EMPTION RIGHTS SECTION 89(1) , PROVIDED THAT THIS POWER IS LIMITED TO THE ALLOTMENT OF EQUITY SECURITIES: 1) WHETHER BY WAY OF RI... | Management | Unknown | For |
14 | AUTHORIZE THE COMPANY TO MAKE MARKET PURCHASES SECTION 163 OF THE ACT OF UP TO 6,186,699 OF ITS ORDINARY SHARES, THE COMPANY SHALL NOT PAY LESS THAN 10P FOR EACH ORDINARY SHARE AND THE COMPANY SHALL NOT PAY MORE FOR EACH ORDINARY SHARE THAN 105% THE AVERAGE OF THE MIDDLE MARKET PRICE OF AN ORDINARY SHARE AS DERIVED FROM THE LONDON STOCK EXCHANGE DAILY OFFICIAL LIST, OVER THE PREVIOUS 5 BUSINESS DAYS; AUTHORITY EXPIRES AT THE CONCLUSION OF THE NEXT AGM OF THE COMPANY ; THE COMPANY, PURSUANT TO... | Management | Unknown | For |
ISSUER NAME: TANOX, INC. MEETING DATE: 06/04/2004 | ||||
TICKER: TNOX SECURITY ID: 87588Q109 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT OSAMA I. MIKHAIL AS A DIRECTOR | Management | For | For |
1.2 | ELECT PETER G. TRABER AS A DIRECTOR | Management | For | For |
2 | TO APPROVE AN AMENDMENT TO THE 2000 NON-EMPLOYEE DIRECTORS STOCK OPTION PLAN. | Management | For | For |
3 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS INDEPENDENT AUDITORS FOR 2004. | Management | For | For |
ISSUER NAME: TECHNE CORPORATION MEETING DATE: 10/23/2003 | ||||
TICKER: TECH SECURITY ID: 878377100 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | TO SET THE NUMBER OF DIRECTORS AT SEVEN. | Management | For | For |
2.1 | ELECT THOMAS E. OLAND AS A DIRECTOR | Management | For | For |
2.2 | ELECT ROGER C. LUCAS, PH.D. AS A DIRECTOR | Management | For | For |
2.3 | ELECT HOWARD V. O'CONNELL AS A DIRECTOR | Management | For | For |
2.4 | ELECT G. ARTHUR HERBERT AS A DIRECTOR | Management | For | For |
2.5 | ELECT RANDOLPH C. STEER AS A DIRECTOR | Management | For | For |
2.6 | ELECT CHRISTOPHER S. HENNEY AS A DIRECTOR | Management | For | For |
2.7 | ELECT ROBERT V. BAUMGARTNER AS A DIRECTOR | Management | For | For |
ISSUER NAME: TELIK, INC. MEETING DATE: 05/12/2004 | ||||
TICKER: TELK SECURITY ID: 87959M109 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT M.M. WICK, M.D., PH.D. AS A DIRECTOR | Management | For | For |
1.2 | ELECT RICHARD NEWMAN, ESQ. AS A DIRECTOR | Management | For | For |
2 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS INDEPENDENT AUDITORS OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2004. | Management | For | For |
ISSUER NAME: THE MEDICINES COMPANY MEETING DATE: 05/27/2004 | ||||
TICKER: MDCO SECURITY ID: 584688105 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT WILLIAM W. CROUSE AS A DIRECTOR | Management | For | For |
1.2 | ELECT T. SCOTT JOHNSON AS A DIRECTOR | Management | For | For |
1.3 | ELECT DAVID M. STACK AS A DIRECTOR | Management | For | For |
2 | RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT AUDITORS FOR THE YEAR ENDING DECEMBER 31, 2004. | Management | For | For |
3 | APPROVE THE COMPANY S 2004 STOCK INCENTIVE PLAN. | Management | For | Against |
ISSUER NAME: TRANSKARYOTIC THERAPIES, INC. MEETING DATE: 06/22/2004 | ||||
TICKER: TKTX SECURITY ID: 893735100 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT MICHAEL J. ASTRUE AS A DIRECTOR | Management | For | For |
1.2 | ELECT WALTER GILBERT AS A DIRECTOR | Management | For | For |
1.3 | ELECT DENNIS H. LANGER AS A DIRECTOR | Management | For | For |
1.4 | ELECT JONATHAN S. LEFF AS A DIRECTOR | Management | For | For |
1.5 | ELECT RODMAN W. MOORHEAD, III AS A DIRECTOR | Management | For | For |
1.6 | ELECT LYDIA VILLA-KOMAROFF AS A DIRECTOR | Management | For | For |
1.7 | ELECT WAYNE P. YETTER AS A DIRECTOR | Management | For | For |
2 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2004. | Management | For | For |
ISSUER NAME: XOMA LTD. MEETING DATE: 05/19/2004 | ||||
TICKER: XOMA SECURITY ID: G9825R107 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT JAMES G. ANDRESS AS A DIRECTOR | Management | For | For |
1.2 | ELECT WILLIAM K. BOWES, JR. AS A DIRECTOR | Management | For | For |
1.3 | ELECT JOHN L. CASTELLO AS A DIRECTOR | Management | For | For |
1.4 | ELECT ARTHUR KORNBERG, M.D. AS A DIRECTOR | Management | For | For |
1.5 | ELECT STEVEN C. MENDELL AS A DIRECTOR | Management | For | For |
1.6 | ELECT P.J. SCANNON, MD, PH.D AS A DIRECTOR | Management | For | For |
1.7 | ELECT W. DENMAN VAN NESS AS A DIRECTOR | Management | For | For |
1.8 | ELECT PATRICK J. ZENNER AS A DIRECTOR | Management | For | For |
2 | PROPOSAL TO APPOINT ERNST & YOUNG LLP TO ACT AS THE COMPANY S INDEPENDENT AUDITORS FOR THE 2004 FISCAL YEAR AND AUTHORIZE THE BOARD TO AGREE TO SUCH AUDITORS FEE. | Management | For | For |
3 | PROPOSAL TO AMEND THE TERMS OF THE COMPANY S 1992 DIRECTORS PLAN, ALL AS MORE FULLY DESCRIBED IN THE PROXY STATEMENT. | Management | For | Against |
4 | PROPOSAL TO AMEND THE TERMS OF THE COMPANY S MANAGEMENT INCENTIVE COMPENSATION PLAN, ALL AS MORE FULLY DESCRIBED IN THE PROXY STATEMENT. | Management | For | For |
5 | PROPOSAL TO APPROVE THE ADOPTION OF THE COMPANY S CEO INCENTIVE COMPENSATION PLAN. | Management | For | For |